Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
Aspivix Selected as Finalist for the 2024 Digital Health Hub Foundation: Digital Health Awards
Los Angeles (United States) - Aspivix is excited to announce its selection as a Finalist for the prestigious 2024 Digital Health Hub Foundation: Digital Health Awards. Aspivix was selected as a Finalist in...
Aspivix and Tia Partner to Enhance IUD procedures with Carevix™ across the USA
Epalinges, Switzerland/Los Angeles, USA – September 19, 2024 - In a groundbreaking partnership aimed at improving women's health, ASPIVIX, a leading innovator in gynecological and fertility solutions, and Tia women's health clinics,...
Aspivix Announces MHRA Approval for the Groundbreaking Cervical Stabilizer Carevix™ for a painless contraceptive care in the United Kingdom
Epalinges, Switzerland – August 26, 2024 - In a significant stride towards transforming women's healthcare, Aspivix, a leading innovator in gynecological solutions, is thrilled to announce that its pioneering device, Carevix™, has...
Femtech Companies to Watch in 2024
From devices and diagnostics to digital health, these femtech companies breathe innovation. Femtech is finally getting its well-deserved time in the limelight as innovative women-led products hit the medtech stage. There are...
Aspivix and Xemperia both receive support from FIT
The Foundation for Technological Innovation is pleased to announce two new loans to Aspivix and Xemperia. Aspivix has been awarded a Tech Growth loan of CHF 500,000 for its non-traumatic device for...
First Successful IUD and Transcervical Procedures with Aspivix’s Non-Traumatic Carevix™ Performed in the US
The first successful IUD and transcervical procedures using Aspivix's non-traumatic carevix™ were performed in the U.S. This milestone underscores the potential of carevix™ to offer a gentler alternative to traditional methods. The procedures...
